Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Roles of ubiquitin signaling in transcription regulation.

Hammond-Martel I, Yu H, Affar el B.

Cell Signal. 2012 Feb;24(2):410-21. doi: 10.1016/j.cellsig.2011.10.009. Epub 2011 Oct 17. Review.

PMID:
22033037
2.

[The role of different E3 ubiquitin ligases in regulation of the P53 tumor suppressor protein].

Daks AA, Melino D, Barlev NA.

Tsitologiia. 2013;55(10):673-87. Review. Russian.

PMID:
25509121
3.

Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors.

Kinyamu HK, Chen J, Archer TK.

J Mol Endocrinol. 2005 Apr;34(2):281-97. Review.

PMID:
15821097
4.

Dysregulation of ubiquitin ligases in cancer.

Qi J, Ronai ZA.

Drug Resist Updat. 2015 Nov;23:1-11. doi: 10.1016/j.drup.2015.09.001. Epub 2015 Sep 28. Review.

5.

Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapy.

Allende-Vega N, Saville MK.

Semin Cancer Biol. 2010 Feb;20(1):29-39. doi: 10.1016/j.semcancer.2009.10.004. Epub 2009 Nov 6. Review.

PMID:
19897040
6.

New Insights into the Role of Ubiquitin Networks in the Regulation of Antiapoptosis Pathways.

Asaoka T, Ikeda F.

Int Rev Cell Mol Biol. 2015;318:121-58. doi: 10.1016/bs.ircmb.2015.05.003. Epub 2015 Jun 17. Review.

PMID:
26315885
7.

Dynamics in the p53-Mdm2 ubiquitination pathway.

Brooks CL, Gu W.

Cell Cycle. 2004 Jul;3(7):895-9. Epub 2004 Jul 2. Review.

PMID:
15254415
8.

Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer.

Voutsadakis IA.

Tumour Biol. 2012 Aug;33(4):897-910. doi: 10.1007/s13277-012-0355-x. Epub 2012 Mar 6. Review.

PMID:
22399444
9.

Ubiquitin-mediated regulation of TNFR1 signaling.

Wertz IE, Dixit VM.

Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):313-24. doi: 10.1016/j.cytogfr.2008.04.014. Epub 2008 Jun 2. Review.

PMID:
18515172
10.

p53 regulation by ubiquitin.

Brooks CL, Gu W.

FEBS Lett. 2011 Sep 16;585(18):2803-9. doi: 10.1016/j.febslet.2011.05.022. Epub 2011 May 27. Review.

11.

Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?

Lamsoul I, Uttenweiler-Joseph S, Moog-Lutz C, Lutz PG.

Biochimie. 2016 Mar;122:339-47. doi: 10.1016/j.biochi.2015.08.003. Epub 2015 Aug 4. Review.

PMID:
26253693
12.
13.

Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms.

de Bie P, Ciechanover A.

Cell Death Differ. 2011 Sep;18(9):1393-402. doi: 10.1038/cdd.2011.16. Epub 2011 Mar 4. Review.

14.

Role of the ubiquitin proteasome system in hematologic malignancies.

Sahasrabuddhe AA, Elenitoba-Johnson KS.

Immunol Rev. 2015 Jan;263(1):224-39. doi: 10.1111/imr.12236. Review.

15.

Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases.

Villeneuve NF, Lau A, Zhang DD.

Antioxid Redox Signal. 2010 Dec 1;13(11):1699-712. doi: 10.1089/ars.2010.3211. Epub 2010 Aug 14. Review.

16.

Protein partners of deubiquitinating enzymes.

Ventii KH, Wilkinson KD.

Biochem J. 2008 Sep 1;414(2):161-75. doi: 10.1042/BJ20080798. Review.

17.

Emerging roles of the ubiquitin-proteasome system in the steroid receptor signaling.

Lee JH, Lee MJ.

Arch Pharm Res. 2012 Mar;35(3):397-407. doi: 10.1007/s12272-012-0301-x. Epub 2012 Apr 5. Review.

PMID:
22477185
18.

A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer.

Satija YK, Bhardwaj A, Das S.

Int J Cancer. 2013 Dec 15;133(12):2759-68. doi: 10.1002/ijc.28129. Epub 2013 Mar 25. Review.

19.

The ubiquitin-proteasome system and cancer.

Devoy A, Soane T, Welchman R, Mayer RJ.

Essays Biochem. 2005;41:187-203. Review.

PMID:
16250906
20.

Proteolytic control of the oncoprotein transcription factor Myc.

Thomas LR, Tansey WP.

Adv Cancer Res. 2011;110:77-106. doi: 10.1016/B978-0-12-386469-7.00004-9. Review.

PMID:
21704229

Supplemental Content

Support Center